Increasing Transparency in Generic Drug Applications Act

Summary

Official

Increasing Transparency in Generic Drug Applications Act This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).

How would you vote on this bill?

Yes No

Bill Progress

Bill has been introduced and assigned a number

Introduced(5/26/22)

Committee

Passed House

Passed Senate

President

Law